Behandlingen kan genoptages ved 400 mg en gang dagligt, når toksiciteten er svundet.
If clinically significant moderate or severe non-haematological toxicity develops, dosing should be interrupted, and may be resumed at 400 mg once daily once the toxicity has resolved.